The authors undertook a meta analysis of nine randomized clinical trials (RCTs) in which modified amino acid solutions that contained supplemental amounts of branched-chain amino acids (BCAA) were compared with other forms of therapy of hepatic encephalopathy (HE). When five RCTs were pooled, analys
Branched chain amino acids in hepatic encephalopathy
โ Scribed by Cerra Fb; Cheung Nk; Fischer Je; Harold O. Conn
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 346 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
After careful analysis of the literature, Eriksson and Conn (1) concluded that branched-chain amino acid (BCAA) therapy does not appear to significantly affect the prognosis of patients with acute hepatic encephalopathy (HE). In a metanalysis of almost the same studies, Naylor et al. (2) reached the
The synthesis of brain glutamate requires an amino group donor that is efficiently transported into the brain and that is readily transaminated. The branchedchain amino acids (BCAA), particularly leucine, play this important role. The uptake of leucine across the blood-brain barrier is faster than a
Branched-chain amino acids (BCAAs) are a group of essential amino acids comprising valine, leucine, and isoleucine. A low ratio of plasma BCAAs to aromatic amino acids is a physiological hallmark of liver cirrhosis, and BCAA supplementation was originally devised with the intention of normalizing am